Company Overview
Crystal Crop Protection is a 1994-incorporated, promoter-led crop solutions company operating an integrated model across agrochemicals and seeds. It manufactures herbicides, fungicides, insecticides, and a natural solutions range including bio-stimulants and micronutrients.
Its seeds vertical covers field crops, vegetables, and marigold with 275+ hybrids and 63 PVP registrations as of June 2026. The company serves Indian farmers through 14,717 distributors and 36 distribution centres across 23 states and four union territories.
R&D collaborations with multinational firms support product development tailored to local agronomy.
Business Model
Revenue is derived from two primary streams: crop protection chemicals and seeds, supplemented by natural crop solutions. The model is fully backward-integrated — spanning R&D, seed breeding, manufacturing, and last-mile distribution — reducing external dependency.
Customers are primarily small and marginal farmers accessed via a dense network of independent distributors. No single distributor or customer concentration risk is disclosed.
Operating leverage depends on monsoon patterns, raw material price cycles (especially technical-grade agrochemical intermediates), and timely regulatory approvals for new registrations.
Industry Context
India’s agrochemical and seed industry is driven by rising farm mechanisation, government push for higher yields, and growing awareness of crop protection. The market is fragmented with strong MNC presence (Bayer, Syngenta, Corteva) and domestic peers like PI Industries, Rallis India, Dhanuka Agritech, and seed players such as Kaveri Seed Company and Nath Bio-Genes.
Crystal’s integrated positioning across both chemicals and seeds differentiates it from pure-play peers. Growth opportunities lie in bio-solutions adoption and hybrid seed penetration, while competitive pricing pressure and regulatory delays remain sector-wide headwinds.
Issue Details & Capital Structure
The IPO opens on November 18, 2026 and closes on November 20, 2026 on the NSE and BSE mainboard. Total issue size is ₹455.49 crore, comprising a fresh issue of ₹354.77 crore (77.9%) and an offer for sale of ₹100.71 crore (22.1%).
Fresh issue proceeds will fund general corporate purposes and business expansion; OFS proceeds go to selling shareholders. Price band and lot size are yet to be announced.
Retail investors should monitor the RHP for final price discovery and minimum application value.
Bidding Schedule & Lot Sizes
Bidding period: November 18–20, 2026. Basis of allotment expected around November 25, 2026 (T+5).
Demat credit of shares by November 27, 2026. Listing tentatively November 28, 2026 (T+3 post-allotment) on NSE and BSE.
Minimum retail lot size and investment amount will be finalised with the price band announcement. Retail investors should ensure UPI mandate readiness and monitor the RHP for exact lot size, price band, and anchor investor allocation details.
Financial Performance & Margins
Consolidated total income grew from ₹2,271.71 crore (FY24) to ₹3,180.98 crore (FY26), a CAGR of ~18.4%. PAT rose from ₹87.24 crore to ₹144.91 crore (CAGR ~29%), with FY26 PAT margin at 4.55%.
EBITDA expanded from ₹209.06 crore to ₹456.23 crore (FY26 margin 14.3%). Total borrowings stood at ₹820.04 crore (FY26) versus net worth of ₹2,039.76 crore, implying a debt-to-equity of ~0.4x.
Reserves grew steadily to ₹1,386.12 crore. Q1 FY27 (June 2026) shows annualised revenue run-rate of ~₹4,800 crore and PAT of ₹135.78 crore, indicating seasonal front-loading.
| Period Ended | 30 Jun 2026 | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|---|
| Assets | 4,498.27 | 3,927.24 | 3,538.43 | 2,541.92 |
| Total Income | 1,209.21 | 3,180.98 | 2,731.94 | 2,271.71 |
| Profit After Tax | 135.78 | 144.91 | 118.39 | 87.24 |
| EBITDA | 241.78 | 456.23 | 315.28 | 209.06 |
| NET Worth | 2,039.76 | 1,600.10 | 1,488.39 | |
| Reserves and Surplus | 1,524.85 | 1,386.12 | 1,296.90 | 1,197.23 |
| Total Borrowing | 952.02 | 820.04 | 947.02 | 577.29 |
Peer Valuation & Industry Comparison
Crystal competes with diversified agrochemical players like PI Industries (strong CSM exports), Rallis India (Tata group, domestic focus), and Dhanuka Agritech (distribution strength). In seeds, peers include Kaveri Seed Company (field crops leader) and Nath Bio-Genes (vegetable seeds).
Crystal’s dual chemicals-seeds integration is relatively unique among listed peers. Its FY26 revenue of ₹3,181 crore places it in the mid-tier; PI Industries and Rallis are larger.
Valuation comparison will depend on the IPO price band. Crystal’s 14.3% EBITDA margin is competitive but below export-oriented peers with higher value-add.
Promoters & Corporate Governance
Promoters are Nand Kishore Aggarwal, Ankur Aggarwal, Komal Aggarwal, and the Ankur Aggarwal KNK Family Trust — a family group with over three decades of operational history since 1994. Ankur Aggarwal leads the second generation.
The board includes experienced professionals, though detailed independent director profiles and committee compositions are not in the provided data. Promoter holding pre-issue and post-issue percentages are not disclosed here.
Governance track record appears stable with no reported regulatory actions, but investors should verify related-party transactions and board independence in the full prospectus.